Pharmacoeconomic Analysis of Two Levofloxacin Therapeutic Schemes for Urinary System Infections
Tang Qing-zhi
Abstract
Tang Qing-zhi
Abstract
Objective:To investigate the economic effects of two levofloxacin therapeutic schemes for urinary system infection. Methods:52 cases of urinary system infection collected from this hospital were divided into two groups:iv levofloxacin group and iv oral sequential levofloxacin group.Clinical effect was observed and cost-effectiveness analysis was carried out.Results:The total costs were 645.20 yuan and 472.04 yuan and the effective rates were 88.46%and 84.62%(P 0.05) in iv levofloxacin group and iv oral sequential group respective.Conclusion:The iv oral sequential levofloxacin scheme is better one for treating urinary system infection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the economic effects of two levofloxacin therapeutic schemes for urinary system infection. Methods:52 cases of urinary system infection collected from this hospital were divided into two groups:iv levofloxacin group and iv oral sequential levofloxacin group.Clinical effect was observed and cost-effectiveness analysis was carried out.Results:The total costs were 645.20 yuan and 472.04 yuan and the effective rates were 88.46%and 84.62%(P 0.05) in iv levofloxacin group and iv oral sequential group respective.Conclusion:The iv oral sequential levofloxacin scheme is better one for treating urinary system infection.
Key concepts: Levofloxacin, Medicine, Urinary system, Urinary infection, Internal medicine, Surgery, Antibiotics, Microbiology